Ahmad Kamran, Saleh Mahnosh, Kakakhel Musa, Yasin Hasina, Ali Yasir, Rehman Hamid Ur, Saeed Usama
Internal Medicine, Hayatabad Medical Complex Peshawar, Peshawar, PAK.
Internal Medicine, Ayub Teaching Hospital, Abbottabad, PAK.
Cureus. 2024 Apr 17;16(4):e58480. doi: 10.7759/cureus.58480. eCollection 2024 Apr.
Sclerosing mesenteritis, a rare fibroinflammatory disease affecting the mesentery, presents a diagnostic challenge due to its varied clinical manifestations and unknown etiology. We present a case of a 50-year-old female presenting with epigastric pain and weight loss, initially suspected of abdominal malignancy. Imaging revealed a mesenteric mass, and histopathological examination confirmed dense lymphoplasmacytic infiltrate with storiform fibrosis, along with elevated serum IgG4 levels, indicative of IgG4-related sclerosing mesenteritis. Treatment with thalidomide and prednisolone resulted in significant mass regression and symptom improvement. Our case highlights the importance of considering sclerosing mesenteritis in the differential diagnosis of abdominal masses and suggests a potential therapeutic approach for this rare condition. Further research is warranted to elucidate its pathogenesis and optimize management strategies.
硬化性肠系膜脂膜炎是一种影响肠系膜的罕见纤维炎性疾病,因其临床表现多样且病因不明,给诊断带来了挑战。我们报告一例50岁女性患者,表现为上腹部疼痛和体重减轻,最初怀疑为腹部恶性肿瘤。影像学检查发现肠系膜肿块,组织病理学检查证实有密集的淋巴浆细胞浸润伴席纹状纤维化,同时血清IgG4水平升高,提示为IgG4相关性硬化性肠系膜脂膜炎。沙利度胺和泼尼松龙治疗导致肿块明显缩小,症状改善。我们的病例强调了在腹部肿块鉴别诊断中考虑硬化性肠系膜脂膜炎的重要性,并提示了针对这种罕见疾病的潜在治疗方法。有必要进一步研究以阐明其发病机制并优化管理策略。